Trials / Terminated
TerminatedNCT04829474
Severe Women Injury Factors Test (SWIFT)
Descriptive Factors of Intimate Partner Violence on Women Related to "Incapacité Totale de Travail" : Multicenter Prospective Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Centre Hospitalier Régional d'Orléans · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Intimate partner violence is a real public health problem, and affects all socio-cultural backgrounds It is defined by behavior within an intimate relationship that causes physical, psychological or sexual harm or suffering to the people in that relationship. Several risk factors exist such as young age, low level of education, exposing to violence during childhood, pregnancy or addictions.
Detailed description
Routine screening is recommended with redaction of medical certificate in which doctor have to determine l'"Incapacité Totale de Travail" corresponding to the duration of discomfort (physical and psychological repercussions) in the activities of daily life. It is a legal notion allows to rule on the responsibility of the author. The sentence is increased if the ITT is greater than 8 days. Worldwide, 30% of women suffered violence whose most common form is intimate partner violence, but legal proceedings have been initiated in less than 25% of the cases. The trauma of women victims of domestic violence worsens with the repetitions of assaults. The investigators suppose that the duration of ITT is an indicator of the severity of the injuries sustained. So, the investigators want to highlight the socio-demographic characteristics and describe the spouse abuse, and then related theese factors to " Incapacité Totale de Travail " (term used in law. It is a scale for assessing the importance of injuries).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey | It is a survey that the patient and doctor must complete. |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2021-07-23
- Completion
- 2021-07-23
- First posted
- 2021-04-02
- Last updated
- 2022-03-21
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04829474. Inclusion in this directory is not an endorsement.